3M Company (MMM)
Industrial / Manufactura diversificada
3M is a diversified industrial conglomerate (safety and industrial, transportation and electronics, consumer) at an inflection point: it completed the exit from PFAS manufacturing and the Solventum spin-off, raised its 2026 adjusted EPS guidance, and returns cash aggressively via buybacks, but trades near its 52-week highs at an already-demanding multiple on adjusted EBIT, with multi-year PFAS and combat earplug litigation as the structural risk that dominates the case.
- Price
- $179.82
- Intrinsic value (5y, base)
- $210
- Total annual return (5y)
- 5.2%
- Status (nominal)
- Fairly valued
- Margin of safety
- +3%
The essentials
- 2026 adjusted EPS guidance raised to $8.80-8.95 after a solid first half, with 70-80 basis points of adjusted operating margin expansion.
- Share buybacks far exceeding the dividend ($4.02bn versus $1.59bn over the last twelve months): cash return to shareholders runs almost entirely through share reduction, not dividends.
- PFAS and combat earplug litigation commit multi-year payments through 2036 and already distort GAAP earnings; adjusted EBIT normalizes those special items for the valuation.
Intrinsic value — two valuation methods
Total return at 5 years: 5.1%/year = 3.2% appreciation + 2.0% dividend. The target price ($210) is ex-dividend; the $19 in dividends collected over 5 years are added separately.
By both methods, the value today (DCF $272 · Multiples $185) exceeds the market price ($180).
Pillars of the analysis
The verdict — today vs 5 years
Today — fairly valued: at $180 trades ~2.9% below its value discounted to today (~$185); the discount is positive but does not reach the margin of safety we require (≥38%).
At 5 years — En valor: the target price ($210) plus dividends yield between the 4% floor and the 10% average return — a reasonable return, though without the margin of a great investment.
The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$117.
Thesis
The business
3M is a mature industrial conglomerate that only recently returned to growth after years of organic contraction, with a real but eroding moat (brands, patents, manufacturing scale) and a balance sheet still burdened by PFAS and combat earplug litigation committing payments through 2036.
The valuation
Valued on EV/EBIT over adjusted EBIT (ex-specials), consistent with the industrial archetype. The base case projects a growth path decelerating from 4.5% to 3.5% annually with gradual margin expansion, capitalized at a 17× multiple on the terminal year's EBIT — resulting in a 5-year value with a +5% annual return at the market price.
The margin of safety
It trades close to intrinsic value, far from the required margin of safety. The current price reflects a recovery the market has already recognized (the stock trades near its 52-week high), so the margin of safety required by the method (§5) determines whether it is worth paying today for a recovery story that still carries multi-year litigation liabilities.
What to watch
The central disconfirmer is the pace and magnitude of PFAS and combat earplug settlement payments: if additional litigation (the AFFF multidistrict litigation, new claims not covered by the existing settlements) exceeds what has already been provisioned, cash available for buybacks shrinks and the share-reduction path that underpins much of the projected return slows down.
Educational / informational. Does not constitute investment advice.